These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 12492023)
21. [HIV and AIDS: experiencing the symptoms. What cell count and viral burden do not tell us]. Holzhemer WL Servir; 2003; 51(3):127-32. PubMed ID: 12889249 [No Abstract] [Full Text] [Related]
22. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death. Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD; HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766 [TBL] [Abstract][Full Text] [Related]
23. Maintaining antiretroviral therapy reduces the risk of AIDS-defining events in patients with uncontrolled viral replication and profound immunodeficiency. Kousignian I; Abgrall S; Grabar S; Mahamat A; Teicher E; Rouveix E; Costagliola D; Clin Infect Dis; 2008 Jan; 46(2):296-304. PubMed ID: 18171266 [TBL] [Abstract][Full Text] [Related]
24. Lymphocyte subsets and viral load in male AIDS patients with major depression: naturalistic study. Huang TL; Leu HS; Liu JW Psychiatry Clin Neurosci; 2006 Dec; 60(6):687-92. PubMed ID: 17109702 [TBL] [Abstract][Full Text] [Related]
25. Why are AIDS dissidents still making 15-year-old, long-refuted claims? Delaney M Nature; 2000 Nov; 408(6810):287. PubMed ID: 11099014 [No Abstract] [Full Text] [Related]
26. The relationship between virologic and immunologic responses in AIDS clinical research using mixed-effects varying-coefficient models with measurement error. Liang H; Wu H; Carroll RJ Biostatistics; 2003 Apr; 4(2):297-312. PubMed ID: 12925523 [TBL] [Abstract][Full Text] [Related]
30. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170. Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM; J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222 [TBL] [Abstract][Full Text] [Related]
31. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. Williams BG; Dye C Science; 2003 Sep; 301(5639):1535-7. PubMed ID: 12920302 [TBL] [Abstract][Full Text] [Related]
33. [AIDS in children (clinico-morphological aspects)]. Iakovtsova AF; Sorokina IV; Korneĭko IV Pediatriia; 1991; (2):100-4. PubMed ID: 2057280 [No Abstract] [Full Text] [Related]
34. The impact of antiretroviral therapy on AIDS and survival. Lundgren JD; Mocroft A J HIV Ther; 2006 Jun; 11(2):36-8. PubMed ID: 16981594 [No Abstract] [Full Text] [Related]
35. 3rd International AIDS Society Conference. Das P Lancet Infect Dis; 2005 Sep; 5(9):541. PubMed ID: 16156006 [No Abstract] [Full Text] [Related]
36. Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status. Zhang R; Xu J; Hong K; Yuan L; Peng H; Tang H; Ma P; Zhang Y; Xing H; Ruan Y; Shao Y AIDS; 2007 Dec; 21 Suppl 8():S9-17. PubMed ID: 18172398 [TBL] [Abstract][Full Text] [Related]